Tenofovir alafenamide
Profile of bictegravir/emtricitabine/tenofovir alafenamide fixed dose combination and its potential in the treatment of HIV-1 infection: evidence to date
... 2) tenofovir alafenamide, a prodrug of tenofovir that concentrates in lymphoid tissue and minimizes off target ...Bictegravir/emtricitabine/tenofovir alafenamide or B/F/TAF is a ...
11
Stability Indicating RP-UPLC-PDA Method Development, Validation of Multi Drug Combination of Emtricitabine, Tenofovir Alafenamide and Rilpivirine in Bulk Drug and its Tablet Formulation
... Tenafovir Alafenamide was proved alternative drug to that of previous analogue, The current work describes the stability indicating accurate, Precise Ultra Performance LC method for quantifying Emtricitabine, ...
5
Analytical method development and validation of Tenofovir Alafenamide by using RP-HPLC of bulk drug
... a nucleotide reverse transcriptase inhibitor and a novel prodrug of tenofovir. It is closely related to tenofovirdisoproxil fumarate but has greater antiviral activity. Mainly used in the treatment of HIV ...
5
Development and Validation of RP-HPLC Method for the Simultaneous Estimation of Tenofovir Alafenamide Fumarate and Emtricitabine in Bulk and Tablet Dosage Form
... action: Tenofovir alafenamide fumarate is a nucleotide reverse transcriptase inhibitor (NRTI) and a novel ester prodrug of the antiretroviral ...to tenofovir, an acyclic nucleoside phosphonate ...
5
Stability indicating RP-HPLC method for simultaneous estimation of emtricitabine, bictegravir and tenofovir alafenamide in bulk and formulation
... Electronics Balance-Denver, P H meter -BVK enterprises, India, Ultrasonicator-BVK enterprises, WATERS HPLC Aquity system equipped with quaternary pumps, UV detector and Auto sampler integrated with Empower 2 Software was ...
12
“Method Development and Validation for Simultaneous Estimation of Emtricitabine, Bictegravir and Tenofovir Alafenamide by RP-HPLC” by Vendra Sri Surya Deepthi, Dr. Devanaboyina Narendra, India.
... 7. Chaitali S Kalamkar and Sanjay B Bhawar, Development and Validation of RP-HPLC Method for the Simultaneous Estimation of Tenofovir Alafenamide Fumarate and Emtricitabine in Bulk and Tablet Dosage Form, ...
6
Darunavir–cobicistat–emtricitabine–tenofovir alafenamide: safety and efficacy of a protease inhibitor in the modern era
... and tenofovir alafenamide (Taf) has been recently approved by the European Medicines Agency for the treatment of HIV infec- tion, and is the first ever protease-inhibitor-based single-tablet ...+ ...
9
Development and Validation of Stability Indicating RP HPLC Method for the Simultaneous Estimation of Emtricitabine Tenofovir Alafenamide Bulk and their Combined Dosage Form
... Emtricitabine tenofovir alafenamide bulk and their combined dosage ...99.96% Tenofovir alafenamide with the value of RSD less than 1% indicating that the proposed method is accurate for the ...
11
Tenofovir alafenamide in the treatment of chronic hepatitis B: design, development, and place in therapy
... Abstract: Tenofovir alafenamide (TAF), a novel prodrug of tenofovir (TFV), has been approved for the treatment of chronic hepatitis B virus (HBV) ...than tenofovir disoproxil fumarate ...
8
Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-experienced, virologically suppressed patients with HIV-1: subgroup analyses of the phase 3 EMERALD study
... emtricitabine/tenofovir alafenamide (FTC/ TAF) vs. emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) as a backbone for treatment of HIV‑1 infection in virologically suppressed adults: subgroup ...
11
Tenofovir alafenamide versus Tenofovir disoproxil: systematic review and meta-analysis (protocol).
... 2015). Tenofovir is specifically a nucleoside reverse transcriptase inhibitor that can cause acute kidney injury (AKI), proximal tubular dysfunction, or both in combination (Antonello ...
15
Renal function change after switching tenofovir disoproxil fumarate for tenofovir alafenamide in the HIV-positive patients of a metropolitan sexual health service
... cART : combination antiretroviral therapy; COBI: cobicistat; E: elvitegravir; EFV: efavirenz; eGFR: estimated glomerular filtration rate; FTC: emtricitabine; RPV: rilpivirine; TAF: ten[r] ...
5
Tenofovir alafenamide fumarate attenuates bleomycin-induced pulmonary fibrosis by upregulating the NS5ATP9 and TGF-β1/Smad3 signaling pathway
... vir alafenamide fumarate (TAF) is widely used to treat human immunodeficiency virus and hepatitis B virus (HBV) infections [25 – ...of tenofovir showed that up to 5 years of treatment with tenofovir ...
13
REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION AND FORCED DEGRADATION STUDIES OF EMTRICITABINE, RILPIVIRINE, AND TENOFOVIR ALAFENAMIDE IN SOLID DOSAGE FORM
... 12. Reddy AP, Teja UC, Sultana SK, Vijayalakshmi M, Nalluri NB. Development and validation of RP-HPLC PDA method for the simultaneous estimation of emtricitabine, tenofovir disoproxil fumarate and rilpivirine ...
5
Rates and predictors of switching to tenofovir alafenamide containing ART in a nationwide cohort
... (especially below 60 mL/min) was a predictor for receiv- ing TAF. This finding is in line with previous reports [16–18] and such a strategy is supported by the results of randomized controlled trials in patients with ...
9
1-s2.0-S2352301818302960-main.pdf
... and tenofovir alafenamide in HIV-1-infected adults with end-stage renal disease on chronic haemodialysis was well tolerated, as evidenced by an overall low incidence of adverse events that were considered ...
10
Antiviral treatment for treatment-naïve chronic hepatitis B: systematic review and network meta-analysis of randomized controlled trials
... telbivudine, tenofovir disoproxil fumarate, tenofovir alafenamide), and the follow- ing published and validated filter was applied: randomized control trials (RCTs) ...
15
1-s2.0-S2352301820300990-main.pdf
... emtricitabine, tenofovir alafenamide group than in the dolutegravir, abacavir, and lamivudine group (38 [12%] of 314 vs 76 [24%] of 315; ...and tenofovir alafenamide group vs 54 [17%] of 315 ...
12
1-s2.0-S0140673617322997-main.pdf
... fovir alafenamide were assessed through an intensive pharmacokinetic substudy done on a non-randomised subset of ...and tenofovir alafenamide, and post-dose pharmacokinetic blood samples were ...
10
Mills_lancet_2016_Switch_TDF_TAF.pdf
... the tenofovir alafenamide regimen (elvitegravir 150 mg, cobicistat 150 mg, emtricitabine 200 mg, and tenofovir alafenamide 10 mg) to four tenofovir disoproxil fumarate-containing ...
10